Please provide your email address to receive an email when new articles are posted on . Treatment with biologic injections may lead to serious complications, such as infections requiring multiple ...

CAMBRIDGE, MA – Sept. 11, 2009 – Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

The phase 3 IRAKLIA trial showed isatuximab's OBDS matches IV efficacy and pharmacokinetics, with fewer injection-site reactions. Subcutaneous isatuximab demonstrated a 71.1% objective response rate, ...

August 13, 2009 (Toronto, Ontario) — When papillary thyroid cancer returns, it is often in the form of metastases to the neck lymph nodes and is usually treated with surgery. But these patients have ...

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs. The Medicines and Healthcare products ...

Aug. 9 (UPI) --The U.S. Food and Drug Administration on Friday announced the approval of the first nasal spray for treatment of anaphylaxis, a life-threatening allergic reaction. The epinephrine nasal ...

Fosfomycin has a novel mechanism of action and is the only IV-administered epoxide antibacterial antibiotic approved in the US Approval marks the second branded product in Meitheal’s portfolio and ...